Effect of posture, hydralazine, and nifedipine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease. 1988

M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, St. Louis, Missouri.

A transient relationship between change in cardiac output (CO) and ventilation and a steady-state relationship between VCO2 and ventilation has been documented. We sought to evaluate the steady-state relationship between CO, and minute ventilation (VE) after positional change and after vasodilator administration in 24 patients with chronic obstructive pulmonary disease (COPD) and mild pulmonary hypertension. Cardiac output was 25% higher (p = 0.003) and VE was 25% lower (p = 0.0001) in the supine position. The change in VE showed a strong correlation with the change in VCO2 (r = 0.693; p = 0.0004), but not with the change in CO. Twelve patients received hydralazine 200 mg orally over 24 h, and 12 patients received nifedipine as a single 10-mg oral dose. Cardiac output increased from 5.05 +/- 1.25 L/min to 6.91 +/- 2.07 L/min (p = 0.008) after hydralazine and increased from 4.34 +/- 1.47 L/min to 5.85 +/- 2.15 L/min (p = 0.001) after nifedipine. Minute ventilation increased from 14.8 +/- 3.0 L/min to 17.3 +/- 4.4 L/min (p = 0.008) after hydralazine, but did not change after nifedipine. The change in VE showed a strong correlation with the change in VCO2 after hydralazine (r = 0.889; p = 0.0004) and after nifedipine (r = 0.756; p = 0.005), but did not correlate with the change in CO. These data demonstrate that the change in VE that accompanies positional change or vasodilator administration in patients with COPD is strongly correlated with the change in VCO2 but not with the change in CO when measured under steady-state conditions.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011187 Posture The position or physical attitude of the body. Postures
D011659 Pulmonary Gas Exchange The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER. Exchange, Pulmonary Gas,Gas Exchange, Pulmonary
D012119 Respiration The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration ( Breathing
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D002245 Carbon Dioxide A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbonic Anhydride,Anhydride, Carbonic,Dioxide, Carbon

Related Publications

M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
October 1984, The American review of respiratory disease,
M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
October 1984, The American review of respiratory disease,
M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
January 1978, The American journal of the medical sciences,
M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
December 1997, American journal of respiratory and critical care medicine,
M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
November 1987, The American journal of medicine,
M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
January 1972, Bulletin de physio-pathologie respiratoire,
M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
June 1978, Pneumonologia polska,
M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
January 1979, Revista paulista de medicina,
M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
January 1986, Respiration; international review of thoracic diseases,
M L Corriveau, and B J Rosen, and C A Keller, and D S Chun, and G F Dolan
January 1976, Scandinavian journal of respiratory diseases,
Copied contents to your clipboard!